Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Bgc Q4 2025 Earnings Bgc Group Inc. Posts 0.31 Eps Topping 0.2929 Analyst Estimates 20260403 FNV FrancoNevada reports 99 percent Q4 2025 EPS beat yet shares drop 169 percent in todays session CVS Health CVS Mifepristone Supreme Court Petition Presents LowRisk Upside Catalyst Pulmatrix PULM Stock Is It Losing Market Strength Johnson Johnson JNJ Icotyde Partnership Drives Portfolio Expansion and DeRisked Biotech Upside Former GEO Group Executive David Venturella Named Acting ICE Director What Is a Rapid Rescore and How Could It Help Improve Your Credit Score New York Fed Study Reveals Rising Gas Prices Disproportionately Impact LowIncome Households Bitcoin Slides as Surging Bond Yields and Inflation Fears Weigh on Risk Assets Couple Feigns Financial Strain to Maintain Social Circle A Behavioral Finance Perspective Ferrari Shares Dip Following Electric Vehicle Unveiling Consumer Credit Growth Accelerates in December Signaling Strong Consumer Spending Amazon Expands AI Shopping Technology to Retailers Signs Kate Spade as First Customer Quanta Services PWR Named Among Louis Navelliers Top LongTerm Picks as Analyst Raises Price Target on Strong Q1 Results Foresight Ventures Leads 30 Million Investment in PopDEX to Drive TraderCentric Perpetual DEX Development MHO Q1 2026 Earnings Earnings Beat Driven by Strong Operational Execution VOYA Q1 2026 Earnings Earnings Beat Driven by Strong Underwriting and Asset Growth Live Ventures Q1 2026 Earnings Diversified Holding Company Reports Positive EPS Amid Market Challenges NPO Q1 2026 Earnings EPS Surpasses Estimates with 17 Beat Stock Rises DTB Q1 2026 Earnings EPS Falls Short of Expectations Amid Flat Market Response MHLA Q3 2024 Earnings Underlying Company Reports Negative EPS No Revenue Data Available Dillards DDS Stages a Modest Recovery Testing Key Resistance Levels WidePoint Corporation WYY Posts Modest Gain Approaches Key Resistance at 1044 Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level Fifth District Bancorp FDSB Narrows Slightly as Support Levels Hold Near 15 Rezolve AI Warrants RZLVW Stabilizes at 093 as Price Action Consolidates Between Key Levels